Since the introduction of the MenA conjugate vaccine in the African meningitis belt through mass vaccination campaigns and its inclusion in the Essential Program on Immunization (EPI), cases of ...

Merck said the facility, which had a ribbon cutting Tuesday, is a 225,000-square-foot state-of-the-art plant, officials said.

Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) has announced its plans to explore utilizing Molecular Envelope Technology (MET) ...

On the five-year anniversary of the Covid pandemic, a Times reporter, Apoorva Mandavilli, looks back at the success of, and the backlash to, the mRNA vaccine. There’s no question that this vaccine ...

Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid development of lifesaving COVID-19 shots. There’s a catch: The mRNA ...

Researchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine.

Vaccine is intended to stimulate T cell responses against targets across the entire genome of the selected virus, similar to company’s lead ...

Bio announced the filing of a new patent with the U.S. Patent and Trademark Office for its under-development T cell vaccine.

Not long after the first flu shot was introduced in 1945 by University of Michigan virologist Thomas Francis and his ...